Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 1Cognitive Dysfunction 1Arthritis 1Agnosia 1

Interventions

Cyclophosphamide 391Carboplatin 345pembrolizumab 332Gemcitabine 332Cisplatin 328Paclitaxel 298Radiotherapy 297Docetaxel 288Bevacizumab 254Rituximab 234Capecitabine 224Nivolumab 222Dexamethasone 206Fluorouracil 191fludarabine 178Oxaliplatin 178Pemetrexed 154Doxorubicin 153Irinotecan 149Leucovorin 145Etoposide 144Cytarabine 134Cetuximab 131fludarabine phosphate 129Bortezomib 129Lenalidomide 126Erlotinib Hydrochloride 121Filgrastim 120Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × acetaminophen, aspirin, caffeine drug combination × Clear all
NCT01264965 2020-12-11

Non-cancer Pain and Cognitive Impairment: A Disabling Relationship

University of Chicago

Phase 4 Terminated
25 enrolled 3 charts

Agnosia, Arthritis, Pain, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡